Semaglutide's data exclusivity in Canada expired on January 5, 2026
& Taylor, M
At excess doses, this pathway could theoretically increase circulating free fatty acids, but no published human trial has reported clinically significant dyslipidemia from acute AOD-9604 overexposure
Visit our pricing page for current rates on all treatments including Semaglutide and Tirzepatide
This powerful peptide, discovered in human plasma decades ago, is now at the forefront of anti-aging research, promising everything from smoother, more youthful skin to fuller, healthier hair
1 As effectiveness of newer dosage forms continues to build, awareness of these drugs rises further (driven by awareness building campaigns) and lower out of pocket costs drive price elasticity, 2 our estimates suggest 1 in 2 eligible adults may adopt a GLP-1 drug over the next 10 year